Market Tracker

06/24 6:45pm ET

SPDR® S&P Biotech ETF (XBI)

Delayed Data
As of Jun 24
 -2.67 / -4.90%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

The 5 Best Healthcare ETFs
Jun 26 / - Paid Partner Content


1 month-7.14% 3 years+16.04%
3 months+3.93% 5 years+17.72%
1 year-38.24% Since inception+12.07%
Data through 06/25/2016

Quote Details

Previous close$54.52
Open day’s range51.85 – 53.39
Net asset value (NAV)51.92 (06/24/2016)
Daily volume11,673,631
Average volume (3 months)7,228,257
Data as of 6:15pm ET, 06/24/2016

Peer Comparisonvs. Health ETFs

Performance 5-yr return+17.72%+15.78%
Expense Gross exp ratio0.35%0.48%
Risk 5 year sharpe ratio0.730.98
Net assets$1.9B$1.2B
Average market cap$3.8B$36.0B
Average P/E--24.4
Dividend / Share--0.22%


XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
VHT Vanguard Health Care Index Fund ETF Shar...


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
ACAD ACADIA Pharmaceuticals Inc3.03%
ANAC Anacor Pharmaceuticals Inc2.70%
MDVN Medivation Inc2.68%
ALKS Alkermes Plc2.43%
NBIX Neurocrine Biosciences Inc2.42%
ICPT Intercept Pharmaceuticals Inc2.18%
NVAX Novavax Inc2.15%
RARE Ultragenyx Pharmaceutical Inc2.10%
SGEN Seattle Genetics Inc2.09%
INCY Incyte Corp2.05%